PŘEHLEDOVÉ ČLÁNKY / REVIEW ARTICLES Post‑sepsis syndrom 20 | ANESTEZIOLOGIE A INTENZIVNÍ MEDICÍNA / Anest intenziv Med. 2025;36(1):15-21 / www.aimjournal.cz 3. Mostel Z, Perl A, Marck M, Mehdi SF, Lowell B, Bathija S, et al. Post‑sepsis syndrome – an evolving entity that afflicts survivors of sepsis. Mol Med. 2020;26:6. 4. Schmidt K, Huelle K, Reinhold T, Prescott H, Gehringer R, Hartmann M, et al. Healthcare Utilization and Costs in Sepsis Survivors in Germany – Secondary Analysis of a Prospective Cohort Study. JCM. 2022;11:1142. 5. Van Der Slikke EC, Beumeler LF, Holmqvist M, Linder A, Mankowski RT, Bouma HR. Understanding Post‑Sepsis Syndrome: How Can Clinicians Help? IDR. 2023;16:6493-511. 6. Wang HE, Szychowski JM, Griffin R, Safford MM, Shapiro NI, Howard G. Long‑term mortality after community‑acquired sepsis: a longitudinal population‑based cohort study. BMJ Open. 2014;4:e004283. 7. Rahmel T, Schmitz S, Nowak H, Schepanek K, Bergmann L, Halberstadt P, et al. Long ‑term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare. PLoS ONE. 2020;15:e0228952. 8. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long‑term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis. JAMA. 2010;304:1787. 9. Prescott HC, Angus DC. Enhancing Recovery From Sepsis: A Review. JAMA. 2018;319:62. 10. Norman BC, Jackson JC, Graves JA, Girard TD, Pandharipande PP, Brummel NE, et al. Employment Outcomes After Critical Illness: An Analysis of the Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors Cohort*. Critical Care Medicine. 2016;44:2003-9. 11. Mankowski RT, Anton SD, Ghita GL, Brumback B, Cox MC, Mohr AM, et al. Older Sepsis Survivors Suffer Persistent Disability Burden and Poor Long‐Term Survival. J American Geriatrics Society. 2020;68:1962-9. 12. Poulsen JB, Møller K, Kehlet H, Perner A. Long‐term physical outcome in patients with septic shock. Acta Anaesthesiol Scand. 2009;53:724-30. 13. Sasegbon A, O’Shea L, Hamdy S. Examining the relationship between sepsis and oropharyngeal dysphagia in hospitalised elderly patients: a retrospective cohort study. Frontline Gastroenterol. 2018;9:256-61. 14. Hongo T, Yumoto T, Naito H, Fujiwara T, Kondo J, Nozaki S, et al. Frequency, associated factors, and associated outcomes of dysphagia following sepsis. Australian Critical Care. 2023;36:521-7. 15. Zielske J, Bohne S, Brunkhorst FM, Axer H, Guntinas‑Lichius O. Acute and long‑term dysphagia in critically ill patients with severe sepsis: results of a prospective controlled observational study. Eur Arch Otorhinolaryngol. 2014;271:3085-93. 16. Zuercher P, Moret CS, Dziewas R, Schefold JC. Dysphagia in the intensive care unit: epidemiology, mechanisms, and clinical management. Crit Care. 2019;23:103. 17. Hayhurst CJ, Jackson JC, Archer KR, Thompson JL, Chandrasekhar R, Hughes CG. Pain and Its Long‑term Interference of Daily Life After Critical Illness. Anesthesia & Analgesia. 2018;127:690-7. 18. Baumbach P, Götz T, Günther A, Weiss T, Meissner W. Prevalence and Characteristics of Chronic Intensive Care–Related Pain: The Role of Severe Sepsis and Septic Shock. Critical Care Medicine. 2016;44:1129-37. 19. Battle CE, Lovett S, Hutchings H. Chronic pain in survivors of critical illness: a retrospective analysis of incidence and risk factors. Crit Care. 2013;17:R101. 20. Koster‑Brouwer ME, Rijsdijk M, Van Os WKM, Soliman IW, Slooter AJC, De Lange DW, et al. Occurrence and Risk Factors of Chronic Pain After Critical Illness. Critical Care Medicine. 2020;48:680-7. 21. Nikayin S, Rabiee A, Hashem MD, Huang M, Bienvenu OJ, Turnbull AE, et al. Anxiety symptoms in survivors of critical illness: a systematic review and meta‑analysis. General Hospital Psychiatry. 2016;43:23-9. 22. Rabiee A, Nikayin S, Hashem MD, Huang M, Dinglas VD, Bienvenu OJ, et al. Depressive Symptoms After Critical Illness: A Systematic Review and Meta‑Analysis. Critical Care Medicine. 2016;44:1744-53. 23. Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic Stress Disorder in Critical Illness Survivors: A Metaanalysis*. Critical Care Medicine. 2015;43:1121-9. 24. Wintermann G‑B, Brunkhorst FM, Petrowski K, Strauss B, Oehmichen F, Pohl M, et al. Stress Disorders Following Prolonged Critical Illness in Survivors of Severe Sepsis: Critical Care Medicine. 2015;43:1213-22. 25. Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhäusler H‑B, Kapfhammer H‑P. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biological Psychiatry. 2001;50:978-85. 26. Altman MT, Knauert MP, Pisani MA. Sleep Disturbance after Hospitalization and Critical Illness: A Systematic Review. Annals ATS. 2017;14:1457-68. 27. Shih C‑Y, Wang A‑Y, Chang K‑M, Yang C‑C, Tsai Y‑C, Fan C‑C, et al. Dynamic prevalence of sleep disturbance among critically ill patients in intensive care units and after hospitalisation: A systematic review and meta‑analysis. Intensive and Critical Care Nursing. 2023;75:103349. 28. Song I‑A, Park HY, Oh TK. Sleep Disorder and Long‑Term Mortality Among Sepsis Survivors: A Nationwide Cohort Study in South Korea. NSS. 2021;Volume 13:979-88. 29. Henríquez‑Beltrán M, Vaca R, Benítez ID, González J, Santisteve S, Aguilà M, et al. Sleep and Circadian Health of Critical Survivors: A 12-Month Follow‑Up Study. Critical Care Medicine. 2024. https://doi.org/10.1097/CCM.0000000000006298. 30. Davydow DS, Hough CL, Langa KM, Iwashyna TJ. Presepsis Depressive Symptoms Are Associated with Incident Cognitive Impairment in Survivors of Severe Sepsis: A Prospective Cohort Study of Older Americans. J American Geriatrics Society. 2012;60:2290-6. 31. Brück E, Schandl A, Bottai M, Sackey P. The impact of sepsis, delirium, and psychological distress on self‑rated cognitive function in ICU survivors – a prospective cohort study. j intensive care. 2018;6:2. 32. Calsavara AJC, Nobre V, Barichello T, Teixeira AL. Post‑sepsis cognitive impairment and associated risk factors: A systematic review. Australian Critical Care. 2018;31:242-53. 33. Pierrakos C, Attou R, Decorte L, Velissaris D, Cudia A, Gottignies P, et al. Cerebral perfusion alterations and cognitive decline in critically ill sepsis survivors. Acta Clinica Belgica. 2017;72:39-44. 34. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long‑term cognitive impairment in survivors of critical illness: Critical Care Medicine. 2010;38:1513-20. 35. Ou S‑M, Chu H, Chao P‑W, Lee Y‑J, Kuo S‑C, Chen T‑J, et al. Long‑Term Mortality and Major Adverse Cardiovascular Events in Sepsis Survivors. A Nationwide Population‑based Study. Am J Respir Crit Care Med. 2016;194:209-17. 36. Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident Stroke and Mortality Associated With New‑Onset Atrial Fibrillation in Patients Hospitalized With Severe Sepsis. JAMA. 2011;306. 37. Walkey AJ, Hammill BG, Curtis LH, Benjamin EJ. Long‑term Outcomes Following Development of New‑Onset Atrial Fibrillation During Sepsis. Chest. 2014;146:1187-95. 38. Gundlund A, Olesen JB, Butt JH, Christensen MA, Gislason GH, Torp‑Pedersen C, et al. One‑year outcomes in atrial fibrillation presenting during infections: a nationwide registry ‑based study. European Heart Journal. 2020;41:1112-9. 39. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta‑analysis. Kidney International. 2012;81:442-8. 40. Mansur A, Mulwande E, Steinau M, Bergmann I, Frederik Popov A, Ghadimi M, et al. Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis. Sci Rep. 2015;5:10539. 41. DeMerle KM, Royer SC, Mikkelsen ME, Prescott HC. Readmissions for Recurrent Sepsis: New or Relapsed Infection?*. Critical Care Medicine. 2017;45:1702-8. 42. Shen H‑N, Lu C‑L, Yang H‑H. Risk of Recurrence After Surviving Severe Sepsis: A Matched Cohort Study. Critical Care Medicine. 2016;44:1833-41. 43. Mira JC, Brakenridge SC, Moldawer LL, Moore FA. Persistent Inflammation, Immunosuppression and Catabolism Syndrome. Critical Care Clinics. 2017;33:245-58. 44. Chadda KR, Puthucheary Z. Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities. British Journal of Anaesthesia. 2024;132:507-18. 45. Nakamura K, Ogura K, Ohbe H, Goto T. Clinical Criteria for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome: An Exploratory Analysis of Optimal Cut‑Off Values for Biomarkers. JCM. 2022;11:5790. 46. Hortová‑Kohoutková M, De Zuani M, Lázničková P, Bendíčková K, Mrkva O, Andrejčinová I, et al. Polymorphonuclear Cells Show Features of Dysfunctional Activation During Fatal Sepsis. Front Immunol. 2021;12. 47. Hortová‐Kohoutková M, Lázničková P, Bendíčková K, De Zuani M, Andrejčinová I, Tomášková V, et al. Differences in monocyte subsets are associated with short‐term survival in patients with septic shock. J Cellular Molecular Medi. 2020;24:12504-12. 48. Chavan SS, Huerta PT, Robbiati S, Valdes‑Ferrer SI, Ochani M, Dancho M, et al. HMGB1 Mediates Cognitive Impairment in Sepsis Survivors. Mol Med. 2012;18:930-7. 49. De Zuani M, Hortová‐Kohoutková M, Andrejčinová I, Tomášková V, Šrámek V, Helán M, et al. Human myeloid‐derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data. Eur J Immunol. 2021;51:1785-91. 50. Van Der Slikke EC, An AY, Hancock REW, Bouma HR. Exploring the pathophysiology of post‑sepsis syndrome to identify therapeutic opportunities. EBioMedicine. 2020;61:103044. 51. Arens C, Bajwa SA, Koch C, Siegler BH, Schneck E, Hecker A, et al. Sepsis‑induced long‑term immune paralysis – results of a descriptive, explorative study. Crit Care. 2016;20:93. 52. Hortová‑Kohoutková M, Tidu F, De Zuani M, Šrámek V, Helán M, Frič J. Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention. Shock. 2020;54:606-14. 53. Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care. 2011;15:R183. 54. Davis FM, Schaller MA, Dendekker A, Joshi AD, Kimball AS, Evanoff H, et al. Sepsis Induces Prolonged Epigenetic Modifications in Bone Marrow and Peripheral Macrophages Impairing Inflammation and Wound Healing. ATVB. 2019;39:2353-66. 55. Hasselgren P‑O. Role of the ubiquitin‑proteasome pathway in sepsis‑induced muscle catabolism. Molecular Biology Reports. 1999;26:71-6. 56. Rocheteau P, Chatre L, Briand D, Mebarki M, Jouvion G, Bardon J, et al. Sepsis induces long‑term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nat Commun. 2015;6:10145. 57. Mankowski RT, Yende S, Angus DC. Long‑term impact of sepsis on cardiovascular health. Intensive Care Med. 2019;45:78-81.
RkJQdWJsaXNoZXIy NDA4Mjc=